{"id":"https://openalex.org/W7145601779","doi":null,"title":"Effects of NMDA receptor antagonists on the binding of agonistic and antagonistic radiotracers to striatal dopamine D2 receptors","display_name":"Effects of NMDA receptor antagonists on the binding of agonistic and antagonistic radiotracers to striatal dopamine D2 receptors","alternate_titles":[],"publication_year":2012,"publication_date":"2012-08-11","ids":{"openalex":"https://openalex.org/W7145601779"},"language":"en","primary_location":{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003830859","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/70852","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"conference output"},"parent_works":[],"lineage":["https://openalex.org/W7145601779"],"child_works_count":0,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repo.qst.go.jp/records/70852","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100534353","display_name":"Masaki Tokunaga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tokunaga, Masaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110940208","display_name":"Jun Maeda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maeda, Jun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132268896","display_name":"Hin Ki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ki, Hin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086758773","display_name":"Chie SEKI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seki, Chie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151144402","display_name":"Yuji Nagai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nagai, Yuji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132208928","display_name":"Ming-Rong Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhang, Ming-Rong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061907383","display_name":"Ryong-Moon Shin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shin, Ryong-Moon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Maruyama, Masahiro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maruyama, Masahiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149648965","display_name":"Maiko Ono","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ono, Maiko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023878612","display_name":"Toshimitsu Fukumura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fukumura, Toshimitsu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058646333","display_name":"Hiroshi Ito","orcid":"https://orcid.org/0000-0002-3581-4798","observed_orcids":["https://orcid.org/0000-0002-3581-4798"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ito, Hiroshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132341461","display_name":"Christer Halldin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Halldin, Christer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085556975","display_name":"Tetsuya Suhara","orcid":"https://orcid.org/0000-0003-2916-225X","observed_orcids":["https://orcid.org/0000-0003-2916-225X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suhara, Tetsuya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132306773","display_name":"Makoto Higuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Higuchi, Makoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045100714","display_name":"\u5fb3\u6c38 \u6b63\u5e0c","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5fb3\u6c38 \u6b63\u5e0c","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039996914","display_name":"\u524d\u7530 \u7d14","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u524d\u7530 \u7d14","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132177739","display_name":"\u5b63 \u658c","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5b63 \u658c","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132319042","display_name":"\u95a2 \u5343\u6c5f","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u95a2 \u5343\u6c5f","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006803039","display_name":"\u6c38\u4e95 \u88d5\u53f8","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u6c38\u4e95 \u88d5\u53f8","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5131920790","display_name":"\u5f35 \u660e\u6804","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5f35 \u660e\u6804","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5131969731","display_name":"\u8f9b \u9f8d\u6587","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u8f9b \u9f8d\u6587","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132218350","display_name":"\u4e38\u5c71 \u5c06\u6d69","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u4e38\u5c71 \u5c06\u6d69","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132145342","display_name":"\u5c0f\u91ce \u9ebb\u8863\u5b50","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5c0f\u91ce \u9ebb\u8863\u5b50","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001477617","display_name":"\u798f\u6751 \u5229\u5149","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u798f\u6751 \u5229\u5149","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132337335","display_name":"\u30cf\u30eb\u30c7\u30a3\u30f3 \u30af\u30ea\u30b9\u30bf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u30cf\u30eb\u30c7\u30a3\u30f3 \u30af\u30ea\u30b9\u30bf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5052337750","display_name":"\u6a0b\u53e3 \u771f\u4eba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u6a0b\u53e3 \u771f\u4eba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.03920000046491623,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.9129999876022339},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.972000002861023},{"id":"https://openalex.org/keywords/11c-raclopride","display_name":"[11C]raclopride","score":0.9980000257492065},{"id":"https://openalex.org/keywords/radioligand-binding","display_name":"radioligand binding","score":0.6769999861717224},{"id":"https://openalex.org/keywords/psychotomimetic-effects","display_name":"psychotomimetic effects","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dopaminergic-neurotransmission","display_name":"dopamine signaling","score":0.843999981880188},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.5460000038146973},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.7770000100135803},{"id":"https://openalex.org/keywords/binding-potential","display_name":"binding potential","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C2781065190","wikidata":"https://www.wikidata.org/wiki/Q7256512","display_name":"Psychotomimetic","level":4,"score":0.9355999827384949},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.7351999878883362},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6567000150680542},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6057000160217285},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.5587000250816345},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5497000217437744},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.48089998960494995},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.46790000796318054},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.462799996137619},{"id":"https://openalex.org/C2778162923","wikidata":"https://www.wikidata.org/wiki/Q4990531","display_name":"Anesthetic","level":2,"score":0.43939998745918274},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.43630000948905945},{"id":"https://openalex.org/C2781069445","wikidata":"https://www.wikidata.org/wiki/Q7279814","display_name":"Raclopride","level":4,"score":0.42179998755455017},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.399399995803833},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3959999978542328},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.3903999924659729},{"id":"https://openalex.org/C2777836312","wikidata":"https://www.wikidata.org/wiki/Q4386371","display_name":"Dizocilpine","level":4,"score":0.3714999854564667},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.3571000099182129},{"id":"https://openalex.org/C187898756","wikidata":"https://www.wikidata.org/wiki/Q395324","display_name":"Agonistic behaviour","level":3,"score":0.34130001068115234},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.336899995803833},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.32440000772476196},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2779591255","wikidata":"https://www.wikidata.org/wiki/Q426081","display_name":"Xylazine","level":3,"score":0.2809000015258789},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.28029999136924744},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.26010000705718994},{"id":"https://openalex.org/C2776359302","wikidata":"https://www.wikidata.org/wiki/Q413918","display_name":"Isoflurane","level":2,"score":0.2506999969482422}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003830859","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/70852","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"conference output"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003830859","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/70852","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"conference output"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2080654671","https://openalex.org/W2099078941","https://openalex.org/W2032558533","https://openalex.org/W2011025664","https://openalex.org/W2054153218","https://openalex.org/W2059329147","https://openalex.org/W2156669782","https://openalex.org/W2129721670","https://openalex.org/W2066431571","https://openalex.org/W2321573383"],"abstract_inverted_index":{"Introduction":[0],"Ketamine":[1,14,398],"and":[2,15,29,32,38,52,121,132,152,197,212,251,278,296,320,330,341,413,435],"phencyclidine":[3],"(PCP)":[4],"act":[5],"as":[6,240,281,404],"noncompetitive":[7],"antagonists":[8,83,99],"to":[9,19,135,166,450],"the":[10,20,25,56,60,78,90,107,113,128,144,171,210,231,259,283,291,360,372,427,466],"N-methyl-D-aspartate":[11],"(NMDA)":[12],"receptor.":[13],"PCP":[16,21,122,252,479],"both":[17,339],"bind":[18],"recognition":[22],"site":[23],"in":[24,75,164,214,282,359,371,380,411,447,453,465],"Ca2+":[26],"channel":[27],"domain,":[28],"exert":[30],"psychotomimetic":[31,85,125,484],"anesthetic":[33,119,422],"effects":[34,86],"at":[35,420,482],"relatively":[36],"low":[37],"high":[39],"doses,":[40],"respectively.":[41],"In":[42,106,139,363,455],"our":[43],"previous":[44],"monkey":[45],"PET":[46,172,178,215,284],"study":[47],"we":[48,110,141],"noticed":[49],"that":[50,80,394,418,442],"ketamine":[51,116,248,277,333,443],"xylazine":[53],"anesthesia":[54],"increased":[55,345],"binding":[57,103,129,325,416,446,459],"potential":[58,225],"of":[59,89,115,130,147,180,194,203,309,352,385,430,469,478],"dopamine":[61,402],"D2":[62,101,137,153,431,470],"receptor":[63,82,98,102,480],"agonist":[64],"[11C]MNPA":[65,388],"(Tokunaga":[66],"et":[67],"al.,":[68],"J":[69],"Neurosci":[70],"2009).":[71],"This":[72],"could":[73,473],"be":[74,474],"line":[76],"with":[77,184,218,237,247,276,303],"view":[79],"NMDA":[81,97,151],"produce":[84],"through":[87],"alterations":[88],"dopaminergic":[91],"neurotransmission.":[92],"However,":[93],"mechanisms":[94],"by":[95,301,346,406],"which":[96,273,472],"modulate":[100],"remain":[104],"unclear.":[105],"present":[108],"study,":[109],"have":[111,142],"investigated":[112],"effect":[114,476],"(at":[117,123],"an":[118,304,421,451,475],"dose)":[120,126],"a":[124,175,185,368,463,483],"on":[127,209,270],"agonistic":[131,195,340,412],"antagonistic":[133,198,342,414],"radioligands":[134,343],"striatal":[136,335,373],"receptors.":[138,154],"addition,":[140],"pursued":[143],"neurochemical":[145],"basis":[146],"this":[148],"crosstalk":[149],"between":[150],"Methods":[155],"Male":[156],"Sprague-Dawley":[157],"rats":[158,181,272],"weighing":[159],"300-400":[160],"g":[161],"were":[162,182,206,228,244,268,274,288,299,344,355],"operated":[163],"order":[165],"fixate":[167],"their":[168],"heads":[169],"during":[170],"measurement":[173],"under":[174],"conscious":[176,271],"state.":[177],"scans":[179],"performed":[183,269,314],"microPET":[186],"FOCUS220":[187],"system":[188],"for":[189,338,375,387,395],"90":[190],"min":[191,257],"after":[192],"administration":[193],"([11C]MNPA)":[196],"([11C]raclopride)":[199],"radiotracers.":[200],"Anatomical":[201],"regions":[202],"interests":[204],"(ROIs)":[205],"manually":[207],"defined":[208],"striatum":[211,292],"cerebellum":[213,238],"images":[216,220],"coregistered":[217],"MR":[219],"using":[221,230,262,315],"PMOD\u00ae":[222],"software.":[223],"Binding":[224],"(BPND)":[226],"values":[227,337],"obtained":[229,317],"multilinear":[232],"reference":[233,241],"tissue":[234],"model":[235],"(MRTM),":[236],"used":[239],"region.":[242],"Rats":[243],"also":[245],"treated":[246,321],"(90":[249],"mg/kg/h)":[250,254],"(3":[253],"starting":[255],"30":[256],"before":[258],"scan":[260],"start":[261],"repeated":[263],"intravenous":[264],"boluses.":[265],"Microdialysis":[266],"studies":[267,366],"pretreated":[275],"PCP,":[279],"similar":[280,409],"measurements.":[285],"Dialysate":[286],"samples":[287],"collected":[289],"from":[290,318,462],"every":[293],"10":[294],"minutes,":[295],"DA":[297,353],"contents":[298,354],"measured":[300,405],"HPLC":[302],"ECD":[305],"system.":[306],"Autoradiographic":[307],"analysis":[308],"coronal":[310],"brain":[311],"sections":[312],"was":[313,326,389],"brains":[316],"untreated":[319],"rats.":[322],"Striatal":[323],"[11C]raclopride":[324],"densitometrically":[327],"quantified.":[328],"Results":[329],"Discussion":[331],"During":[332],"anesthesia,":[334],"BPND":[336,386],"approximately":[347],"20%,":[348],"while":[349],"ketamine-induced":[350,369],"changes":[351],"barely":[356],"detectableby":[357],"microdialysis":[358],"rat":[361],"striatum.":[362],"vitro":[364],"autoradiography":[365,439],"demonstrate":[367],"increase":[370,384,410,452],"Bmax":[374],"[11C]raclopride,":[376],"but":[377],"no":[378],"change":[379,464],"Kd.":[381],"The":[382,408,438],"PCP-induced":[383],"however":[390],"significantly":[391],"larger":[392],"than":[393],"[11C]raclopride.":[396],"Conclusion":[397],"did":[399],"not":[400,425],"modify":[401],"levels":[403],"microdialysis.":[407],"radioligand":[415,445,458],"indicated":[417],"ketamine,":[419],"dose,":[423],"does":[424],"alter":[426],"functional":[428,467],"states":[429,468],"receptors":[432],"(i.e.":[433],"high-affinity":[434],"low-affinity":[436],"states).":[437],"results":[440],"confirm":[441],"enhances":[444],"vivo":[448],"due":[449],"Bmax.":[454],"contrast,":[456],"PCP-enhanced":[457],"may":[460],"result":[461],"receptors,":[471],"characteristic":[477],"ligands":[481],"dose.":[485]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7145601779","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2026-04-01T00:00:00"}
